Luoding Weiguang Dancai Plasma Company announced that it will receive CNY 3,000,000 in an equity round of funding on July 22, 2017. The transaction will include participation from returning investor, Shenzhen Weiguang Biological Products Co.,Ltd (SZSE:002880) to maintain its 100% stake in the company.